The New Healthcare Playbook: Automation, Devices, and Demographics

Good morning, ! This week we’re diving into robotics in healthcare, healthtech VC deal activity update, medical implants and devices competitive landscape, and the investment opportunity that the aging population presents. 

Want to advertise in Healthcare 150? Check out our ad platform, here.

Know someone in the healthcare space who should see this? Forward it their way. Here’s the link.

— The Healthcare150 Team

DATA DIVE

Robotics Becomes Healthcare Infrastructure

Healthcare robotics is rapidly evolving from a niche surgical technology into a core component of healthcare infrastructure. The market is projected to grow from $3.8 billion in 2016 to $21.1 billion by 2029, reflecting a fundamental shift in how providers deliver care, manage operations, and address workforce shortages.

While robotic-assisted surgery remains the dominant application, accounting for more than 60% of market activity, the next growth wave is emerging outside the operating room. Hospitals are increasingly deploying robots for pharmacy automation, supply transport, laboratory workflows, disinfection, and rehabilitation. These applications offer faster implementation, lower clinical risk, and compelling returns on investment.

The sector remains significantly underpenetrated. Healthcare accounts for just 6,200 professional service robots globally, compared to 113,000 in transportation and logistics, highlighting substantial room for expansion. At the same time, AI integration is making robotic systems smarter, improving surgical precision, reducing complications, and enhancing workflow efficiency.

Market leaders such as Intuitive Surgical, Medtronic, Stryker, and Johnson & Johnson are building integrated ecosystems that combine robotics, software, imaging, analytics, and recurring service revenue. As hospitals move from pilot programs to institutional adoption, healthcare robotics is increasingly becoming a strategic necessity rather than a competitive differentiator.

Read the Full Report HERE

HEALTHTECH CORNER

The New Rules of Healthtech Investing

The healthtech funding boom may be over, but the sector's next chapter is beginning to take shape.

After peaking at $30.8B in venture funding in 2021, the market spent the next three years correcting excesses built during the pandemic era. Yet the latest PitchBook data suggests that the reset may be ending. Healthtech startups raised $16.5B in 2025, while Q1 2026 funding reached $4.6B, up 25.4% year-over-year, with deal activity increasing 35.5%.

But this is not a return to the old market.

Capital is becoming increasingly selective, flowing toward companies with clear business models, proven ROI, and meaningful AI capabilities. The largest rounds this year—from OpenEvidence to WHOOP and Qualified Health—highlight a growing preference for platforms that combine healthcare workflows with scalable AI infrastructure.

For investors, the message is straightforward: the easy money phase of digital health is over. The next winners will likely be companies building durable, AI-enabled healthcare infrastructure rather than pursuing growth at any cost. (More)

PRESENTED BY PARTICLE FOR MEN

Eye Bags Make You Look Tired. Fix That.

The best investors know small problems compound fast. Eye bags and tired skin are no different. You need to address them early, before they become the new normal.

That’s why Particle Anti-Aging Face Cream sold out so quickly once founders and investors discovered it. More than 1 million men now use it to combat eye bags, wrinkles, and dark spots. The 6-in-1 formula combines 12 high-grade ingredients in a single anti-aging solution built for men.

If you want that sharper, younger look that signals energy, discipline, and confidence, this is the move. Use code “150” for 20% OFF and free shipping before it sells out again.

Learn More

COMPETITIVE LANDSCAPE SNAPSHOT

TREND TO WATCH

The Aging Population's Next Investment Opportunity

Private equity deal activity in Personal, Preventive & Managed Care (PPM) has cooled dramatically since its pandemic-era peak, falling from more than 300 transactions in late 2021 to fewer than 100 deals per quarter today.

But the slowdown may be masking a much bigger story.

Demand for elderly care, home-based services, and chronic care management continues to rise as populations age and healthcare systems struggle with capacity constraints. At the same time, operators face mounting labor shortages, reimbursement pressure, and increasing technology requirements—all factors that make scale more valuable.

This combination of demographic tailwinds and operational complexity is creating fertile ground for consolidation. While investors have remained cautious amid higher financing costs and valuation resets, the long-term investment thesis remains intact.

For investors, the question is not whether demand for elderly and preventive care will grow. It is who will build the platforms capable of delivering these services at scale. The next wave of healthcare consolidation may not happen in hospitals or physician practices—it may happen in the home.

Learn more

"You are never too old to set another goal or to dream a new dream."

C.S. Lewis